Anti-Alzheimer’s Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Alzheimer’s Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
Authors
Keywords
-
Journal
Marine Drugs
Volume 19, Issue 5, Pages 251
Publisher
MDPI AG
Online
2021-04-28
DOI
10.3390/md19050251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent
- (2021) Eshak I. Bahbah et al. Marine Drugs
- Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer’s Disease
- (2021) Md. Sahab Uddin et al. NEUROCHEMICAL RESEARCH
- Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
- (2020) Md. Tanvir Kabir et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Combination Drug Therapy for the Management of Alzheimer’s Disease
- (2020) Md. Tanvir Kabir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease
- (2020) Abdullah Al Mamun et al. Oxidative Medicine and Cellular Longevity
- Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
- (2020) Md. Sahab Uddin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
- (2020) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Treatment Combinations for Alzheimer’s Disease: Current And Future Pharmacotherapy Options
- (2019) Jeffrey L. Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Simplified immunosuppressive and neuroprotective agents based on gracilin A
- (2019) Mikail E. Abbasov et al. Nature Chemistry
- Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
- (2019) Stephanie Andrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gracilin A Derivatives Target Early Events in Alzheimer’s Disease: in Vitro Effects on Neuroinflammation and Oxidative Stress
- (2019) Rebeca Alvariño et al. ACS Chemical Neuroscience
- Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status
- (2019) Julien Delrieu et al. Alzheimers & Dementia
- Gracilin-Derivatives as Lead Compounds for Anti-inflammatory Effects
- (2019) Sandra Gegunde et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery
- (2018) Xiang Rong Tian et al. Future Medicinal Chemistry
- GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy
- (2018) Stefan J. Schaller et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Bryostatin-1 alleviates experimental multiple sclerosis
- (2018) Michael D. Kornberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
- (2018) Fuyuki Kametani et al. Frontiers in Neuroscience
- Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
- (2018) Inger Vedin et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Enhanced Brain Amyloid-β Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer's Disease
- (2018) Hisham Qosa et al. JOURNAL OF ALZHEIMERS DISEASE
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
- (2018) Martin R. Farlow et al. JOURNAL OF ALZHEIMERS DISEASE
- Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials
- (2017) Thomas J. Nelson et al. JOURNAL OF ALZHEIMERS DISEASE
- Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
- (2017) Sandrine Andrieu et al. LANCET NEUROLOGY
- Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
- (2017) Nicholas Israel Nii-Trebi Biomed Research International
- Reversal of cognitive decline in Alzheimer's disease
- (2016) Dale Bredesen et al. Aging-US
- Marine-Derived Pharmaceuticals - Challenges and Opportunities
- (2016) Ulrike Lindequist Biomolecules & Therapeutics
- Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers
- (2016) Tomohiro Umeda et al. BRAIN
- Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2016) Yu Yamazaki et al. CNS DRUGS
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease
- (2016) Beata Pająk et al. Oxidative Medicine and Cellular Longevity
- A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
- (2016) William James Deardorff et al. Drug Design Development and Therapy
- Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
- (2016) Vishruti Makani et al. Acta Neuropathologica Communications
- Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
- (2015) L.M. Schrott et al. Current Alzheimer Research
- New Drugs from Marine Organisms in Alzheimer’s Disease
- (2015) Patrizia Russo et al. Marine Drugs
- Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: Role of pregnane X receptors
- (2015) P. Kaur et al. NEUROSCIENCE
- The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer’s disease in vitro and in vivo
- (2015) M. Leirós et al. NEUROSCIENCE
- Towards universal therapeutics for memory disorders
- (2015) Miao-Kun Sun et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Beyond Acetylcholinesterase Inhibitors for Treating Alzheimer&aposs Disease: .α7-nAChR Agonists in Human Clinical Trials
- (2014) Patrizia Russo et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Spongionella Secondary Metabolites Protect Mitochondrial Function in Cortical Neurons against Oxidative Stress
- (2014) Marta Leirós et al. Marine Drugs
- Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
- (2014) Ana Martins et al. Marine Drugs
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
- (2014) Takahisa Kanekiyo et al. Frontiers in Aging Neuroscience
- Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease
- (2014) J. Carson Smith et al. Frontiers in Aging Neuroscience
- Mitigation of ROS Insults by Streptomyces Secondary Metabolites in Primary Cortical Neurons
- (2013) Marta Leirós et al. ACS Chemical Neuroscience
- Benefit of 13-desmethyl Spirolide C Treatment in Triple Transgenic Mouse Model of Alzheimer Disease: Beta-Amyloid and Neuronal Markers Improvement
- (2013) Eva Alonso et al. Current Alzheimer Research
- Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
- (2013) Mirjana B. Colovic et al. Current Neuropharmacology
- Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
- (2013) Y. Freund Levi et al. JOURNAL OF INTERNAL MEDICINE
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- PKC activation during training restores mushroom spine synapses and memory in the aged rat
- (2013) Jarin Hongpaisan et al. NEUROBIOLOGY OF DISEASE
- Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
- (2013) J. A. Moreno et al. Science Translational Medicine
- Modification of the Relationship of the Apolipoprotein E ε4 Allele to the Risk of Alzheimer Disease and Neurofibrillary Tangle Density by Sleep
- (2013) Andrew S. P. Lim et al. JAMA Neurology
- AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
- (2012) Satoshi Mizuno et al. BMC Systems Biology
- 3-(2,4-Dimethoxybenzylidene)-anabaseine: A promising candidate drug for Alzheimer's disease?
- (2012) Philippe Zawieja et al. Geriatrics & Gerontology International
- A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial
- (2012) D. William Molloy et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Bryostatin-1 vs. TPPB: Dose-Dependent APP Processing and PKC-α, -δ, and -ε Isoform Activation in SH-SY5Y Neuronal Cells
- (2012) P. Yi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Recruitment strategies for preventive trials. The MAPT study (Multidomain Alzheimer Preventive Trial)
- (2012) I. Carrie et al. Journal of Nutrition Health & Aging
- Effects of DHA- Rich n-3 Fatty Acid Supplementation on Gene Expression in Blood Mononuclear Leukocytes: The OmegAD Study
- (2012) Inger Vedin et al. PLoS One
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Anatabine lowers Alzheimer's Aβ production in vitro and in vivo
- (2011) Daniel Paris et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antibody-based therapy in Alzheimer's disease
- (2011) Refik Pul et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- PKC Activation Prevents Synaptic Loss, A Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice
- (2011) J. Hongpaisan et al. JOURNAL OF NEUROSCIENCE
- 13-Desmethyl spirolide-C is neuroprotective and reduces intracellular Aβ and hyperphosphorylated tau in vitro
- (2011) Eva Alonso et al. NEUROCHEMISTRY INTERNATIONAL
- Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
- (2011) Haythum O. Tayeb et al. PHARMACOLOGY & THERAPEUTICS
- RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
- (2010) Gizem Donmez et al. CELL
- Bryostatins: biological context and biotechnological prospects
- (2010) Amaro E Trindade-Silva et al. CURRENT OPINION IN BIOTECHNOLOGY
- Marine natural products as sources of novel scaffolds: achievement and concern
- (2010) De-Xin Kong et al. DRUG DISCOVERY TODAY
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
- (2010) Joseph F. Quinn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review Article: Genetics of Alzheimer Disease
- (2010) Lynn M. Bekris et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Total synthesis of (−)-dictyostatin, a microtubule-stabilising anticancer macrolide of marine sponge origin
- (2010) Ian Paterson et al. TETRAHEDRON
- Late onset Alzheimer’s disease in older people
- (2010) Ahmet Turan Isik Clinical Interventions in Aging
- Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
- (2009) Sophie Gillette-Guyonnet et al. Alzheimers & Dementia
- Bioactive Diterpene Derivatives from the Marine SpongeSpongionellasp.
- (2009) Mostafa E. Rateb et al. JOURNAL OF NATURAL PRODUCTS
- Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: The Alzhemedtm (Tramiprosate) experience
- (2009) D. Saumier et al. Journal of Nutrition Health & Aging
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
- (2008) Elliott J Mufson et al. Expert Review of Neurotherapeutics
- Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains
- (2008) M.-K. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Amyloid Fibrillization of Hen Egg-White Lysozymes by Rifampicin and p-Benzoquinone
- (2007) Valerie H. Lieu et al. BIOTECHNOLOGY PROGRESS
- Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
- (2007) Yvonne Freund-Levi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now